CN101862399B - Medicine for preventing and treating pediatric saprodontia and preparation method thereof - Google Patents

Medicine for preventing and treating pediatric saprodontia and preparation method thereof Download PDF

Info

Publication number
CN101862399B
CN101862399B CN2010102103216A CN201010210321A CN101862399B CN 101862399 B CN101862399 B CN 101862399B CN 2010102103216 A CN2010102103216 A CN 2010102103216A CN 201010210321 A CN201010210321 A CN 201010210321A CN 101862399 B CN101862399 B CN 101862399B
Authority
CN
China
Prior art keywords
parts
grams
medicine
preventing
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN2010102103216A
Other languages
Chinese (zh)
Other versions
CN101862399A (en
Inventor
赵丽侠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Li He
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010102103216A priority Critical patent/CN101862399B/en
Publication of CN101862399A publication Critical patent/CN101862399A/en
Application granted granted Critical
Publication of CN101862399B publication Critical patent/CN101862399B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to medicine for preventing and treating pediatric saprodontia, which belongs to a medical agent prepared from the following raw medicine by weight parts: 4 to 8 parts of radix scutellariae, 6 to 10 parts of magnolia officinalis, 1 to 5 parts of forsythia, 1 to 3 parts of capillary artemisia, 1 to 5 parts of nutgall, 3 to 6 parts of honeysuckle, 1 to 5 parts of acanthopanax, 10 to 15 parts of green tea, 3 to 7 parts of safflower and 10 to 20 parts of honey. The invention also provides a preparation method of the medicine for preventing and treating pediatric saprodontia. The recipe of the medicine for preventing and treating pediatric saprodontia of the invention is simple, the price is low, the curative effect is obvious, the patient adaptability is strong, and the invention is suitable for being widely popularized in clinics.

Description

A kind of medicine of preventing and treating pediatric saprodontia and preparation method thereof
Technical field
The present invention relates to field of medicaments, specifically, relate to a kind of medicine of preventing and treating pediatric saprodontia and preparation method thereof.
Background technology
The fluoride preventing decayed tooth has experienced more than 40 year; comprise fluoridation of drinking water, contain fluorine-added milk or fluorine-containing Sal, the part is coated with fluorine multiple measures such as (toothpaste with fluoride, fluoride gel, fluorine-containing collutorys); because fluoride is the caries incidence among the reduction crowd to some extent, and be acknowledged as effectively preventing decayed tooth measure on the our times.The medical circle of oral cavity personage once proposed " the fluoride preventing decayed tooth is one of great achievement in 20th century oral cavity preventive medicine ", but fluoride is still controversial problem in the stomatology field so far to the measurement of human body pros and cons.It seems that at present the use of fluoride preparation has tangible limitation, as dental fluorosis, skeletal fluorosis etc.Therefore, seek the attention that new safe and effective no fluoride preparation more and more is subjected to dental caries prevention and control field scholars.
At present, also use some antibacterial to prevent and treat dental caries.Life-time service broad spectrum antimicrobicide and chemical synthetic drug when removing oral cavity pathogen, have destroyed the ecological balance in oral cavity.Simultaneously, some side effect may appear in the prolonged application antimicrobial drug, as edema, hypertension, bring out and increase the weight of to infect etc.And the antibiotics topical application is easy to produce drug resistance, and long-term topical application also can cause dysbacteriosis and fungal infection.The situation of above-mentioned situation in children's is particularly evident.And if use has the Chinese medicine of antibacterial action, when suppressing pathogenic bacterium, can not destroy the ecological balance in oral cavity." back to nature ", " green remedy " are accepted by more people with its distinctive curative effect and safety simultaneously.In recent years, Chinese medicine is applied to prevent and treats the pharmacology of dental caries and the research of mechanism begins to be subjected to the concern and the attention of Chinese scholars, and obtained progress preferably.Therefore develop a kind of determined curative effect, the convenient and practical medicine of preventing and treating dental caries is becoming inevitable.
Summary of the invention
The purpose of this invention is to provide a kind of medicine of preventing and treating pediatric saprodontia.
The present invention also aims to provide the preparation method of the medicine of described control pediatric saprodontia.
In order to realize method of the present invention, the invention provides a kind of medicine of preventing and treating pediatric saprodontia, it is the medicament of being made according to weight portion by following raw material medicaments: 10~20 parts of 4~8 parts of Radix Scutellariaes, 6~10 parts of Cortex Magnoliae Officinalis, 1~5 part of Fructus Forsythiae, 1~3 part of Herba Artemisiae Scopariae, 1~5 part of Galla Chinensis, 3~6 parts of Flos Loniceraes, 1~5 part of Radix Et Caulis Acanthopanacis Senticosi, 10~15 parts of green tea, 3~7 parts on Flos Carthami and Mel.
Preferably, it is the medicament of being made according to weight portion by following raw material medicaments: 15 parts of 5 parts of Radix Scutellariaes, 8 parts of Cortex Magnoliae Officinalis, 3 parts of Fructus Forsythiaes, 1 part of Herba Artemisiae Scopariae, 3 parts of Galla Chinensiss, 5 parts of Flos Loniceraes, 1 part of Radix Et Caulis Acanthopanacis Senticosi, 10 parts of green tea, 5 parts on Flos Carthami and Mel.
Preferably, the medicine of control pediatric saprodontia of the present invention is buccal tablet or collutory.
The present invention also provides a kind of preparation method of preventing and treating the medicine of pediatric saprodontia, this method comprises the following steps: to take by weighing Radix Scutellariae 50 grams, Cortex Magnoliae Officinalis 80 grams, Fructus Forsythiae 30 grams, Herba Artemisiae Scopariae 10 grams, Galla Chinensis 30 grams, Flos Lonicerae 50 grams, Radix Et Caulis Acanthopanacis Senticosi 10 grams, green tea 100 grams, Flos Carthami 50 grams, Mel 150 grams and water 500 grams, place in the flask of sealing, heating is 2 hours under 70 ℃ water-bath, filter, collect filtrate and promptly get collutory.
The drug prescription of control pediatric saprodontia of the present invention is simple, is common Chinese medicine, low price, and curative effect is clear and definite, and patient adaptability is strong, is suitable for large-scale popularization clinically.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
Embodiment 1
Take by weighing Radix Scutellariae 50 grams, Cortex Magnoliae Officinalis 80 grams, Fructus Forsythiae 30 grams, Herba Artemisiae Scopariae 10 grams, Galla Chinensis 30 grams, Flos Lonicerae 50 grams, Radix Et Caulis Acanthopanacis Senticosi 10 grams, green tea 100 grams, Flos Carthami 50 grams, Mel 150 grams and water 500 grams, place in the flask of sealing, heating is 2 hours under 70 ℃ water-bath, filter, collect filtrate and promptly get collutory.
When using collutory, generally once use 10-20ml.When using collutory of the present invention, can repeatedly gargle after the meal, also can once suck several minutes.Collutory can be told, and also can directly swallow.
Experimental example 1: to the external bacteriostatic activity research of cariogenic bacteria
Streptococcus mutans, actinomyces viscosus are considered to most important cariogenic bacteria, and they form dental plaque by the adhesion to facing, and it is bad to make tooth produce dental caries, therefore suppresses and kill cariogenic bacteria to have important effect to preventing and treating dental caries.In this experimental example, adopt filter paper method classical in this area to carry out bacteriostatic test, wherein:
1. material
1.1 for the examination strain
Actinomyces viscosus (A.viscosus ATCC 15987) and Streptococcus mutans (S.mutans ATCC 25175) are stepped on bio tech ltd available from Shanghai three.
1.2 culture fluid
Nutrient agar and nutrient broth are stepped on bio tech ltd available from Shanghai three.
1.3 test method
Actinomyces viscosus (A.viscosus ATCC 15987) and Streptococcus mutans (S.mutans ATCC 25175) are inoculated on the agar plate nutritional solution plane, evenly gather during inoculation.The aseptic circular filter paper sheet of tweezer immerses the collutory among the embodiment 1, fully behind the dipping, is attached on the agar plate nutritional solution plane of inoculated bacteria.Agar plate placed in 37 ℃ the incubator incubation 24 hours.Measure the diameter of antibacterial ring.Measuring 3 times averages.
1.4 result
The average diameter of the antibacterial ring of actinomyces viscosus (A.viscosus ATCC 15987) is 30.34 mm, the average diameter of the antibacterial ring of Streptococcus mutans (S.mutans ATCC 25175) is 26.47mm, shows that collutory of the present invention has tangible fungistatic effect.
Experimental example 2
1. clinical data
Select 40 examples shallow in the dental caries children as the object of observation, all meet " cariology " (the Yue Songling chief editor. the 1st edition, Chengdu: the Sichuan People's Press, 1983:224-225, diagnosis 280-281) and calibration standard.Be divided into test group and matched group at random.Test group 20 examples wherein, the range of age are 4-7 year, average 5.6 years old, and each 10 example of men and women wherein; Matched group 20 examples, the range of age are 4-7 year, average 5.4 years old, and each 10 example of men and women wherein.
2. observational technique
Test group is used the collutory that makes among the embodiment 1, is all gargling after the meal every day 3 times, each 20ml, and gargle got final product in 30 seconds, and 3 months is 1 course of treatment.Matched group is not used collutory of the present invention.The diet of test group and matched group every day is all identical with the daily life custom.
3. efficacy assessment standard
Adopt the standard of plaque index variation as efficacy assessment standard.Plaque index reduced being assessed as more than 1 effectively, plaque index is remained unchanged or increase be assessed as more than 1 invalid.
(plaque index PLI) is proposed in 1964 by Silness and Loe plaque index, keeps the score and does not keep the score according to the bacterial plaque area coverage according to the thickness of pressure surface bacterial plaque.Be used to estimate the oral hygiene situation and weigh the periodontal disease prevention effect.
With the method inspection of the bonding probes of inspection, inspection is with the probe facing that rows dry, and keeps the score according to the amount and the thickness of bacterial plaque.Plaque index section checks the dental pattern face, also can check several selected teeth.Every tooth is all checked 4 facings, promptly near middle buccal surface, center buccal surface, middle buccal surface far away and lingual surface.Keeping the score of every tooth is that 4 facings are kept the score sum divided by 4, the individual keep the score for every tooth somewhat sum divided by being examined the tooth number.
0=gum edge district does not have bacterial plaque;
The facing in 1=gum edge district has thin bacterial plaque, but inspection is invisible, if can hang up bacterial plaque with the side of probe pinpoint;
2=is in gum edge or the visible moderate bacterial plaque of proximal surface;
It is a large amount of soft enough that in the 3=gingival sulcus or gum edge district is that proximal surface has.
According to before the said method determination test and the plaque index after course of treatment, and change according to plaque index and to obtain following result of the test.
4. result of the test
For test group, there is 15 routine patients' plaque index minimizing 2,5 routine patients' plaque index to reduce 1.For matched group, the plaque index that 16 routine patients' plaque index increases by 1,4 routine patient increases by 2.
Experimental example 3: mouthfeel
Experimenter that please 20 routine test group uses the collutory of embodiment 1.20 patients all represent the good mouthfeel of this collutory, wherein have 8 to be that the patient just swallows under the situation of not doing any suggestion or hint voluntarily.
Experimental example 4: the implication situation in oral cavity
20 routine test group experimenters' implication is comparatively pure and fresh, even the fragrance of tea is arranged.And the implication of the experimenter in the 20 routine matched groups comparatively is difficult to stand, 15 examples even loathsome sensation arranged.

Claims (3)

1. medicine of preventing and treating pediatric saprodontia, it is characterized in that it is the medicament of being made according to weight portion by following raw material medicaments: 10~20 parts of 4~8 parts of Radix Scutellariaes, 6~10 parts of Cortex Magnoliae Officinalis, 1~5 part of Fructus Forsythiae, 1~3 part of Herba Artemisiae Scopariae, 1~5 part of Galla Chinensis, 3~6 parts of Flos Loniceraes, 1~5 part of Radix Et Caulis Acanthopanacis Senticosi, 10~15 parts of green tea, 3~7 parts on Flos Carthami and Mel, described medicament is buccal tablet or collutory.
2. the medicine of control pediatric saprodontia according to claim 1 is characterized in that it is the medicament of being made according to weight portion by following raw material medicaments: 15 parts of 5 parts of Radix Scutellariaes, 8 parts of Cortex Magnoliae Officinalis, 3 parts of Fructus Forsythiaes, 1 part of Herba Artemisiae Scopariae, 3 parts of Galla Chinensiss, 5 parts of Flos Loniceraes, 1 part of Radix Et Caulis Acanthopanacis Senticosi, 10 parts of green tea, 5 parts on Flos Carthami and Mel.
3. preparation method of preventing and treating the medicine of pediatric saprodontia, this method is made up of the following step: take by weighing Radix Scutellariae 50 grams, Cortex Magnoliae Officinalis 80 grams, Fructus Forsythiae 30 grams, Herba Artemisiae Scopariae 10 grams, Galla Chinensis 30 grams, Flos Lonicerae 50 grams, Radix Et Caulis Acanthopanacis Senticosi 10 grams, green tea 100 grams, Flos Carthami 50 grams, Mel 150 grams and water 500 grams, place in the flask of sealing, heating is 2 hours under 70 ℃ water-bath, filter, collect filtrate promptly.
CN2010102103216A 2010-06-28 2010-06-28 Medicine for preventing and treating pediatric saprodontia and preparation method thereof Expired - Fee Related CN101862399B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010102103216A CN101862399B (en) 2010-06-28 2010-06-28 Medicine for preventing and treating pediatric saprodontia and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010102103216A CN101862399B (en) 2010-06-28 2010-06-28 Medicine for preventing and treating pediatric saprodontia and preparation method thereof

Publications (2)

Publication Number Publication Date
CN101862399A CN101862399A (en) 2010-10-20
CN101862399B true CN101862399B (en) 2011-08-31

Family

ID=42954457

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010102103216A Expired - Fee Related CN101862399B (en) 2010-06-28 2010-06-28 Medicine for preventing and treating pediatric saprodontia and preparation method thereof

Country Status (1)

Country Link
CN (1) CN101862399B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2523619C2 (en) * 2012-07-02 2014-07-20 Максим Александрович Шевченко Method of treating dentin caries in permanent teeth in children with incomplete solid tissue mineralisation (versions)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102309663B (en) * 2011-09-09 2013-01-16 靳霞 Medicament for controlling dental caries
CN103006513A (en) * 2012-12-28 2013-04-03 青岛爱维互动信息技术有限公司 Chinese herbal medicine mouthwash
CN103933454A (en) * 2014-04-14 2014-07-23 青岛市市立医院 Traditional Chinese medicine for treating saprodontia caused by noxious dampness fumigation and preparation method thereof
CN104940438A (en) * 2015-06-16 2015-09-30 方克贵 Chinese herbal medicine extract and toothpaste for preventing and treating childhood caries, and application of Chinese herbal medicine extract

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1179972A (en) * 1997-09-29 1998-04-29 杨成玉 Multifunctional effervescent for cleaning mouth
CN101152453A (en) * 2007-09-20 2008-04-02 吴月 Traditional Chinese medicine for treating chronic gingivitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1179972A (en) * 1997-09-29 1998-04-29 杨成玉 Multifunctional effervescent for cleaning mouth
CN101152453A (en) * 2007-09-20 2008-04-02 吴月 Traditional Chinese medicine for treating chronic gingivitis

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
卫田江等.育阴煎加味治疗牙痛38例.《医学理论与实践》.1993,第6卷(第06期),48. *
周学东等.黄芩对三种主要致龋菌生长、产酸及产胞外多糖的影响.《华西医科大学学报》.2002,第33卷(第03期),391-393. *
李君等.复方中药漱口剂对变形链球菌致龋的实验研究.《浙江医学》.2004,第26卷(第03期),187-189. *
黄文柱.牙痛方治疗牙痛48例.《陕西中医》.1995,第16卷(第11期),509. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2523619C2 (en) * 2012-07-02 2014-07-20 Максим Александрович Шевченко Method of treating dentin caries in permanent teeth in children with incomplete solid tissue mineralisation (versions)

Also Published As

Publication number Publication date
CN101862399A (en) 2010-10-20

Similar Documents

Publication Publication Date Title
Messier et al. Licorice and its potential beneficial effects in common oro‐dental diseases
CN101862399B (en) Medicine for preventing and treating pediatric saprodontia and preparation method thereof
CN104244912B (en) Have and alleviate oral cavity pain and kill oral cavity bacterium and the natural antibacterial dentifrice composition of stable neural effect
Wiatrak et al. Oral health of patients treated with acrylic partial dentures using a toothpaste containing bee product
CN109528601A (en) Herbal mixture mouthwash and preparation method thereof
CN103908423B (en) Anti-oral helicobacter pylori Chinese medicinal toothpaste
Rahmatova Modern prevention and effective treatment of dental caries in children
Subramaniam et al. The effect of different concentrations of Neem (Azadiractha indica) leaves extract on the inhibition of Streptococcus mutans (In vitro)
CN102188408A (en) New preparation formulation-paper patch used for preventing diseases of local oral cavity
CN107485584A (en) A kind of oral care composition
Alhamadani et al. Clinical study on the therapeutic effects of Quercus infectoria galls as oral powder in gingivitis and plaque patients
CN102309663B (en) Medicament for controlling dental caries
CN107362112B (en) Gum-protecting and healing toothpaste
CN102961728B (en) Medicament for preventing and treating children saprodontia
CN102580035B (en) Medicament for treating periodontitis
CN104940438A (en) Chinese herbal medicine extract and toothpaste for preventing and treating childhood caries, and application of Chinese herbal medicine extract
Kim et al. Comparison of Oral Disease Prevention Effects between Saline and Glycyrrhiza Uralensis Mouthwash
Mishra To Evaluate The Effects Of Rinsing With Green Tea On Streptococcus Mutans Count In Plaque And To Compare The Efficacy Of Green Tea With That Of Chlorhexidine Mouth Wash And Plain Water On The Streptococcus Mutans Count In Plaque: A Randomized Controlled Trial
Nair Comparative Evaluation of Two Herbal Toothpastes on Salivary Streptococcus Mutans Counts, Lactobacillus Counts, Plaque and Gingival Status–An in Vivo Study
CN100525799C (en) Pharmaceutical composition for preventing and/or treating oral disease caused by microbe
Baek Screening of antimicrobial activity among the therapeutic herbal extracts on dental pathogens
Sharma et al. To Ascertain If Bracket Material Difference (Polycarbonate And Stainless Steel) Has An Effect On Streptococcus Mutans Count In Orthodontic Patients When Used With Herbal Dentifrices.
El-sayed et al. Evaluation of the antimicrobial effect of propolis extract on oral microflora
De Oliveira The Effect of a Homoeopathic and Herbal Mouthwash Formulation on the Growth of Streptococcus salivarius and Fusobacterium nucleatum in vitro
Ahmed et al. Evaluation of the Effect of Ginger and Chlorhexidine as Mouthwashes on Streptococcus Mutans in Saliva in a Group of Egyptian Children

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
ASS Succession or assignment of patent right

Owner name: TIANJIANG PHARMACEUTICAL INDUSTRY CO., LTD., JIANG

Free format text: FORMER OWNER: ZHAO LIXIA

Effective date: 20130625

C41 Transfer of patent application or patent right or utility model
COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 272100 JINING, SHANDONG PROVINCE TO: 214400 WUXI, JIANGSU PROVINCE

TR01 Transfer of patent right

Effective date of registration: 20130625

Address after: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8

Patentee after: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin

Address before: 272100 children's Dental Department of Jining Stomatological Hospital of Shandong Province

Patentee before: Zhao Lixia

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20170619

Address after: 075700, No. 118, village gate, Yangchun Town, Zhangjiakou, Hebei, Weixian County

Patentee after: Li He

Address before: 214400 Jiangyin Economic Development Zone, Jiangsu, Qin Shan Road, No. 8

Patentee before: Tianjiang Pharmaceutical Industry Co., Ltd., Jiangyin

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20110831

Termination date: 20170628

CF01 Termination of patent right due to non-payment of annual fee